In focus
Latest feed
Wockhardt Secures US FDA Approval for Zaynich, Shifts Gears from Lab Bench to Marketplace
Navin Fluorine's Bold Leap: A Rs 1,400 Crore Bet on the Future of Fluorochemicals
Delhi Pollution's Unseen Cost: Akums Drugs CFO Exits Amid IPO Preparations
Indian Pharma Eyes Major Gains as US BIOSECURE Act Targets Chinese Biotech
